Stay updated and stay ahead of industry trends
We were honored to attend this academic conference, showcasing our newly developed glycan analysis enzymes and antibody analysis enzymes, while engaging in in-depth discussions on cutting-edge biopharmaceutical R&D technologies with leading experts.
After two years of R&D, we introduce a glycerol-free PNGase F optimized for mass spectrometry, delivering lower background interference for high-precision glycosylation analysis.
Overview of Key Technological Breakthroughs in Antibody Drug Glycosylation Analysis: Optimizing the Full Workflow of IdeS Digestion Coupled with LC-MS/MS
Share tips on using Trypsin/Lys-C Mix for digesting complex proteomics samples to improve peptide coverage and identification success.
According to the latest market research report, the global biosimilars market is expected to continue growing, with originator comparison and glycan profile consistency evaluation becoming key factors.
Overview: The critical role of high-purity tool enzymes in biotherapeutic release testing, stability studies, and batch-to-batch consistency evaluation, along with key method validation considerations.